1[10]Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study,final results.Circulation,1991;84:527
2[11]Petersen P , Boysen G , Godtfredsen J,et al.Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation:The Copenhagen AFASAK study.Lancet,1989;1:175
3[12]Stroke Prevention in Atrial Fibrillation Investigators.Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation:Stroke Prevention in Atrial Fibrillation Ⅱ study.Lancet,1994;343:687
5[14]Ang SY, Peterson GM, Friesen WT,et al.Review of antithrombotic drug usage in atrial fibrillation. J Clin Pharm Ther,1998 Apr;23:97
6[1]Kannel WB, Abbot RD,Savage DD,et al.Epidemiologic features of chronic atrial fibrillation:the Framingham study.N Engl J Med,1982,306:1018
7[2]Furberg CD, Psaty BM, Manolio TA,et al.Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol,1994 Aug 1,74:236
8[3]Levy S, Novella P, Ricard P,et al.Paroxysmal atrial fibrillation: a need for classification. J Cardiovasc Electrophysiol,1995 Jan; 6:69
9[4]Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke,1986 Jul-Aug;17:622
10[5]Yamanouchi H , Mizutani T, Matsushita S,et al. Paroxysmal atrial fibrillation: high frequency of embolic brain infarction in elderly autopsy patients. Neurology,1997 Dec;49:1691
